EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Trends in lung cancer survival: superior outcomes in US Veterans compared with the general population

Nikki E Rossetti iD, Brendan T Heiden iD, Daniel B Eaton, Steven Tohmasi iD, Nahom Seyoum, Theodore Thomas, Martin Schoen, Whitney S Brandt, Sara Malone, Yan Yan, Ana Baumann iD, Su-Hsin Chang iD und 6 weitere

JNCI Cancer Spectrum · 2026

DOI: 10.1093/jncics/pkag054 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JNCI Cancer Spectrum, 2026. Verfasst von Nikki E Rossetti und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Veterans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, HSRD VA, Veterans Health Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality in the United States, but survival outcomes are shifting with evolving therapies and screening. Recent findings suggest that survival improvements vary across health-care systems, with favorable trends observed in the Veterans Health Administration (VHA). We sought to compare NSCLC survival trends across US health systems.

Methods

We conducted a retrospective cohort study of patients with NSCLC (2007-2019) using data from the VHA and the National Cancer Database (NCDB), representing the non-VHA US general population. The primary exposure was health system (VHA vs non-VHA), and the primary outcome was 3-year all-cause mortality. Multivariable Cox models estimated annual adjusted overall survival (OS), with interaction terms for health system and stage.

Results

Among 1 463 996 patients (VHA n = 79 027; NCDB n = 1 38 4 969), adjusted 3-year OS increased from 24% to 51% (VHA) and from 24% to 41% (non-VHA) between 2007 and 2019. The VHA survival advantage persisted in analyses stratified by stage (all P-values <.0001) and when analyses were limited to NCDB patients with Medicare or private insurance (51% vs 42% in 2019; P < .0001)

Conclusions

In this nationally representative study, 3-year OS among patients with NSCLC improved between 2007 and 2019, with larger and more rapid gains observed within the VHA compared with non-VHA settings. These findings suggest that lung cancer care delivered within an integrated, publicly funded system is associated with greater and more rapidly improving survival than care delivered across a heterogeneous mix of US health-care delivery settings represented in the NCDB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungVeteransHumansUnited StatesFemaleRetrospective StudiesMaleAgedMiddle AgedProportional Hazards ModelsUnited States Department of Veterans AffairsAged, 80 and over

Autor:innen und Institutionen

  • Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States.
  • Department of Surgery, St. Louis VA Medical Center, St. Louis, MO, United States.
  • Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
  • Department of Medicine, St. Louis VA Medical Center, St. Louis, MO, United States.
  • Department of Medicine, Saint Louis University School of Medicine, St. Louis, MO, United States.

ORCID-Profile: Nikki E Rossetti, Brendan T Heiden, Steven Tohmasi, Ana Baumann, Su-Hsin Chang

Förderung

  • NCI NIH HHS
  • HSRD VA
  • Veterans Health Administration
  • National Cancer Institute

Zitieren

APA

Rossetti, N. E., Heiden, B. T., Eaton, D. B., Tohmasi, S., Seyoum, N., Thomas, T., Schoen, M., Brandt, W. S., Malone, S., Yan, Y., Baumann, A., Chang, S. H., Patel, M., Kreisel, D., Nava, R., Meyers, B., Kozower, B., & Puri, V. (2026). Trends in lung cancer survival: superior outcomes in US Veterans compared with the general population. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag054

Vancouver

Rossetti NE, Heiden BT, Eaton DB, Tohmasi S, Seyoum N, Thomas T, et al. Trends in lung cancer survival: superior outcomes in US Veterans compared with the general population. JNCI Cancer Spectrum. 2026. doi:10.1093/jncics/pkag054

BibTeX
@article{Rossetti2026,
  author = {Rossetti, Nikki E and Heiden, Brendan T and Eaton, Daniel B and Tohmasi, Steven and Seyoum, Nahom and Thomas, Theodore and Schoen, Martin and Brandt, Whitney S and Malone, Sara and Yan, Yan and Baumann, Ana and Chang, Su-Hsin and Patel, Mayank and Kreisel, Daniel and Nava, Ruben and Meyers, Bryan and Kozower, Benjamin and Puri, Varun},
  title = {Trends in lung cancer survival: superior outcomes in US Veterans compared with the general population},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  doi = {10.1093/jncics/pkag054}
}
Kostenlos starten →